Aqueous gel formulations containing immune response modifiers
Aqueous gel formulations, including an immune response modifier (IRM), such as those chosen from imidazoquinoline amines, tetrahydroimidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, 1,2-bridged imidazoquinoline amines, imidazonaphthyridine amines, imidazotetrahydronaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, oxazolopyridine amines, thiazolopyridine amines, oxazolonaphthyridine amines, thiazolonaphthyridine amines, pyrazolopyridine amines, pyrazoloquinoline amines, tetrahydropyrazoloquinoline amines, pyrazolonaphthyridine amines, tetrahydropyrazolonaphthyridine amines, and 1H-imidazo dimers fused to pyridine amines, quinoline amines, tetrahydroquinoline amines, naphthyridine amines, or tetrahydronaphthyridine amines, are provided. Methods of use and kits are also provided.
3M Innovative Properties Company
A A A A A A A A A A A A A A A A A A A A A
A61K A61P A61P A61P A61K A61K A61K A61K A61M A61K A61P A61P A61K A61P A61P A61P A61P A61K A61P A61K A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional additional inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional
Christopher S. Raymond D. John C. David Q.
Perman Skwierczynski Hedenstrom Ma